ARQ 092 enhances the Efficacy of Paclitaxel, Lapatinib, Trastuzumab, Trametinib, and ARQ 087 both in Cancer Cell Lines and Mouse Xenograft Cancer Models

Thursday, November 12, 2015   Posters and Presentations

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300